Dimensional Fund Advisors’s Lyell Immunopharma LYEL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-13,463
| Closed | -$7.24K | – | 3309 |
|
2025
Q1 | $7.24K | Hold |
13,463
| – | – | ﹤0.01% | 3318 |
|
2024
Q4 | $8.62K | Sell |
13,463
-3,138
| -19% | -$2.01K | ﹤0.01% | 3337 |
|
2024
Q3 | $22.9K | Sell |
16,601
-23,497
| -59% | -$32.4K | ﹤0.01% | 3329 |
|
2024
Q2 | $58.1K | Buy |
40,098
+26,635
| +198% | +$38.6K | ﹤0.01% | 3299 |
|
2024
Q1 | $30K | Hold |
13,463
| – | – | ﹤0.01% | 3353 |
|
2023
Q4 | $26.1K | Hold |
13,463
| – | – | ﹤0.01% | 3381 |
|
2023
Q3 | $19.8K | Hold |
13,463
| – | – | ﹤0.01% | 3443 |
|
2023
Q2 | $42.8K | Sell |
13,463
-29,282
| -69% | -$93.1K | ﹤0.01% | 3417 |
|
2023
Q1 | $101K | Sell |
42,745
-91,849
| -68% | -$217K | ﹤0.01% | 3297 |
|
2022
Q4 | $467 | Buy |
134,594
+15,321
| +13% | +$53 | ﹤0.01% | 3046 |
|
2022
Q3 | $874K | Buy |
+119,273
| New | +$874K | ﹤0.01% | 2919 |
|